文献速递系统性红斑狼疮

双歧杆菌改善狼疮肾炎并调节淋巴细胞亚群的异常分化

Bifidobacterium ameliorates lupus nephritis and modulates aberrant differentiation of lymphocyte subsets.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

研究收集61例系统性红斑狼疮(SLE)患者临床样本,用流式细胞术分析CD4+ T细胞和B细胞亚群,ELISA检测细胞因子和自身抗体,16S rRNA测序比较肠道菌群。SLE患者肠道菌群丰度和多样性降低,尤其双歧杆菌减少;在MRL/lpr小鼠中补充双歧杆菌、其总代谢物及短链脂肪酸(SCFAs)可纠正CD4+ T细胞和B细胞亚群及细胞因子失衡,降低自身抗体水平并减轻肾损伤。

要点

  • SLE患者肠道菌群丰度和多样性降低,尤其双歧杆菌减少。
  • 狼疮肾炎(LN)患者记忆B细胞、中央记忆T细胞、Treg细胞及IL-2比例降低,效应记忆T细胞、Th1、Th17细胞、IL-10及IFN-γ升高。
  • MRL/lpr小鼠补充双歧杆菌、其总代谢物及SCFAs可纠正免疫细胞与细胞因子失衡、降低自身抗体并减轻肾损伤。

核心结论

  • 双歧杆菌在SLE患者中显著减少,影响LN的肾损伤和免疫细胞平衡。
  • 在MRL/lpr小鼠中补充双歧杆菌、其总代谢物及SCFAs可显著改善肾损伤并恢复免疫细胞平衡。

研究设计与样本

  • 研究收集61例SLE患者临床样本,采用流式细胞术分析CD4+ T细胞和B细胞亚群,ELISA检测人及小鼠模型细胞因子和自身抗体,16S rRNA测序比较患者肠道菌群丰度并筛选潜在益生菌。
  • 在MRL/lpr小鼠中给予双歧杆菌、其总代谢物及SCFAs,通过组织病理学检查和免疫荧光染色评估肾损伤改善。

主要发现

  • SLE患者肠道菌群丰度和多样性降低,尤其双歧杆菌减少。
  • LN患者记忆B细胞、中央记忆T细胞、Treg细胞及IL-2比例降低,效应记忆T细胞、Th1和Th17细胞、IL-10及IFN-γ升高。
  • 补充双歧杆菌、其代谢物及SCFAs可纠正CD4+ T细胞和B细胞亚群及细胞因子水平失衡,降低小鼠自身抗体水平并减轻肾损伤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The gut microbiota is crucial in the progression of lupus nephritis (LN), and probiotics have emerged as a potential therapeutic approach. This study investigates the role of Bifidobacterium in LN pathogenesis and its effects on immune cell populations. METHODS: Clinical samples were collected from 61 systemic lupus erythematosus (SLE) patients, and flow cytometry was used to analyse changes in CD4+ T- and B-cell subsets. ELISA quantified cytokine secretion and autoantibodies in both human and murine models. Additionally, 16S rRNA sequencing identified variations in gut microbiota abundance among patients and helped screen for potential probiotics. Histopathological examination and immunofluorescence staining assessed kidney injury improvements in MRL/lpr mice treated with Bifidobacterium, its total metabolites and short-chain fatty acids (SCFAs). RESULTS: SLE patients showed decreased gut microbiota abundance and diversity, particularly a reduction in Bifidobacterium. Clinical data revealed lower proportions of memory B cells, central memory T cells, Treg cells and IL-2, alongside increased effector memory T cells, Th1 and Th17 cells, IL-10 and IFN-γ in LN patients. Supplementation with Bifidobacterium, its metabolites and SCFAs corrected the imbalances in CD4+ T- and B-cell subsets and cytokine levels, reduced autoantibody levels in mice and alleviated kidney damage. CONCLUSIONS: Bifidobacterium is significantly diminished in SLE patients, influencing kidney injury and immune cell balance in LN. Moreover, Bifidobacterium, its total metabolites and SCFAs' supplementation in MRL/lpr mice notably improved kidney damage and restored immune cell equilibrium in MRL/lpr mice.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wu L, Guan Z, Zhang X, et al. Bifidobacterium ameliorates lupus nephritis and modulates aberrant differentiation of lymphocyte subsets. Rheumatology (Oxford). 2025. PMID: 40411762. doi:10.1093/rheumatology/keaf271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。